The rate of insulin nonpersistence among patients with type II diabetes who were first started on insulin treatment [İlk Kez İnsülin Tedavisi Başlanan Tip 2 Diyabetik Hastalarda İnsülin Bırakma Oranı]

Basit Öğe Kaydı
dc.contributor.authorKarabayraktar T.
dc.contributor.authorTekin B.
dc.contributor.authorTekin S.
dc.contributor.authorSargin M.
dc.date.accessioned2024-07-12T21:56:50Z
dc.date.available2024-07-12T21:56:50Z
dc.date.issued2017en_US
dc.departmentMaltepe Üniversitesien_US
dc.description.abstractObjective: Our aim in this study is to assess the rate and possible causes of nonpersistence among patients with diabetes who have received standard insulin education for their insulin treatment. Material and Methods: 700 patients with type II diabetes, who were started on insulin treatment by outpatient clinics of Dr. Lütfi Kırdar Kartal Training and Research Hospital between 1/1/2012-1/1/2013, and who had received the same standard insulin education given by diabetes nurses, were enrolled in this study. Patients were called by the phone and a questionnaire was filled regarding patients' socio-demographic characteristics, comorbidities and patients' insulin use. We have reached 462 patients/relatives. Total of 14 patients died, and 23 patients, whose insulin treatment was nonpersistent by a physician, were excluded. 425 patients were included in the final analysis. Results: Among 425 patients, 50.8% were male, mean age was 57.7 years (±11.6 years) and average time since diabetes diagnosis was 6.6 years (±6.2 years). 57.6% were on basal, 17.9% on premixed and 24.5% were on basal-bolus insulin regimen. The rate of nonpersistence was found to be 6.2%. Non-parametric correlation tests revealed that compliance rates significantly increased with increased age (p=0.01, r=0.12). Most common causes of nonpersistence were hypoglycemia, fatigue (26.9%), feeling good and cured (23%) and difficulties in injections (15.3%) allergy 11.5%, environmental factors 7.6%, and fear of addiction 7.6%. Conclusions: Detecting the underlying causes of nonpersistence of insulin by the healthcare centers that initiated the treatment, and utilizing these data for revising standard insulin education programs could be a key factor for reaching the desired glycemic goals in patients with diabetes. © 2017 by Türkiye Klinikleri.en_US
dc.identifier.doi10.5336/medsci.2017-55949
dc.identifier.endpage129en_US
dc.identifier.issn1300-0292
dc.identifier.issue3en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage124en_US
dc.identifier.urihttps://dx.doi.org/10.5336/medsci.2017-55949
dc.identifier.urihttps://hdl.handle.net/20.500.12415/8614
dc.identifier.volume37en_US
dc.language.isotren_US
dc.publisherTurkiye Kliniklerien_US
dc.relation.ispartofTurkiye Klinikleri Journal of Medical Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKY03795
dc.subjectDiabetes mellitusen_US
dc.subjectInsulinen_US
dc.subjectMedication adherenceen_US
dc.titleThe rate of insulin nonpersistence among patients with type II diabetes who were first started on insulin treatment [İlk Kez İnsülin Tedavisi Başlanan Tip 2 Diyabetik Hastalarda İnsülin Bırakma Oranı]en_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu